Jennison Associates’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $9.07M | Buy |
|
|||||
|
2023
Q3 | $11.4M | Sell |
|
|||||
|
2023
Q2 | $46.6M | Buy |
|
|||||
|
2023
Q1 | $52.6M | Sell |
|
|||||
|
2022
Q4 | $37.4M | Buy |
|
|||||
|
2022
Q3 | $28.9M | Sell |
|
|||||
|
2022
Q2 | $24.3M | Sell |
|
|||||
|
2022
Q1 | $47.6M | Buy |
|
|||||
|
2021
Q4 | $36M | Buy |
|
|||||
|
2021
Q3 | $58.1M | Buy |
|
|||||
|
2021
Q2 | $57.6M | Sell |
|
|||||
|
2021
Q1 | $58.7M | Sell |
|
|||||
|
2020
Q4 | $62.4M | Sell |
|
|||||
|
2020
Q3 | $57.5M | Buy |
|
|||||
|
2020
Q2 | $51.9M | Buy |
|
|||||
|
2020
Q1 | $25.2M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $864K | Sell |
|
|||||
|
2018
Q2 | $31.1M | Sell |
|
|||||
|
2018
Q1 | $45.7M | Buy |
|
|||||
|
2017
Q4 | $30.7M | Buy |
|
|||||
|
2017
Q3 | $10.4M | Sell |
|
|||||
|
2017
Q2 | $9.99M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $2.33M | Buy |
|
|||||
|
2015
Q2 | $2.48M | Sell |
|
|||||
|
2015
Q1 | $2.27M | Buy |
|
|||||
|
2014
Q4 | $1.85M | Sell |
|
|||||
|
2014
Q3 | $5.78M | Sell |
|
|||||
|
2014
Q2 | $38.1M | Buy |
|
|||||
|
2014
Q1 | $5.51M | Buy |
|